There is a strong anticipated future for human pluripotent stem cell-derived hepatocytes 17 (hiPS-HEP), but so far their use has been limited due to insufficient functionality. We investigated 18 the potential of hiPS-HEP as an in vitro model for metabolic diseases by combining transcriptomics 19 with multiple functional assays. The transcriptomics analysis revealed that 86% of the genes were 20 expressed at similar levels in hiPS-HEP as in human primary hepatocytes (hphep). Adult 21 characteristics of the hiPS-HEP were confirmed by the presence of important hepatocyte features, 22 e.g. Albumin secretion and expression of major drug metabolizing genes. Normal energy 23 metabolism is crucial for modeling metabolic diseases, and both transcriptomics data and functional 24 assays showed that hiPS-HEP were similar to hphep regarding uptake of glucose, LDL and fatty 25 acids. Importantly, the inflammatory state of the hiPS-HEP was low under standard conditions, but 26 in response to lipid accumulation and ER stress the inflammation marker TNFα was upregulated.
151 II enzymes as well as transporter proteins, is of critical importance for the utility of an in vitro 152 hepatocyte model in drug metabolism and hepatotoxicity studies but of less importance for disease 153 modeling. Since several enzymes are known to be specific for fetal or adult hepatocytes, analyses of 154 these enzymes can also aid to assess the grade of maturity of the cells.
155
We started by investigating the most important Cytochrome P450 (CYP) enzymes and found 156 that several CYP enzymes were expressed in hiPS-HEP at similar mRNA levels as in hphep d1, e.g., enzymes with the lowest correlation between mRNA and activity levels [15] . This clearly emphasizes 177 that protein expression or preferably functional assays are essential when characterizing in vitro 178 hepatocyte models.
179
Since drug metabolism is also performed by phase II enzymes, we investigated the expression 180 of two classes of phase II enzymes, sulfotransferases (SULT) and UDP-glucuronosyl transferases 181 (UGT) . All tested SULTs and UGTs were found to be expressed on similar mRNA levels between the 182 two cell types ( Figure 2B ). In agreement with that, incubations with the substrate 7-OH-coumarin 183 revealed similar or higher SULT and UGT activity levels in hiPS-HEP and in hphep cultured for 20 h 184 (including the activity assay; Fig 2E and F) . Similarly to the CYP activities, phase II enzyme activities 185 were stable or even increasing in hiPS-HEP during a 14-day culture period (between day 4-19 post-186 thaw).
187
Besides phase I and II enzymes, transporter proteins play an important role in xenobiotics 188 metabolism. Therefore, we also investigated the mRNA expression of 19 transporters, including both 189 uptake and efflux transporters. 11 transporters were expressed on similar levels in both cell types, 190 e.g., ABCC2 (MRP2) and SLC10A1 (NTCP), whereas eight were expressed at lower levels in hiPS-
191
HEP, e.g., ABCB11 (BSEP) and SLCO1B1 (OATP1B1; Figure 2C ). The protein expression of MRP2,
192
NTCP, BSEP, and OATP1B1 were confirmed by immunostainings ( Figure 2G1 -4). 
194

225
First, we compared the mRNA expression of more than 40 genes central in glucose metabolism 226 in hiPS-HEP and hphep and found the vast majority to be expressed at similar levels in both cell types 227 ( Figure 3A ). Only eight of the genes were significantly differently expressed between hiPS-HEP and 228 hphep d0 and/or d1. The genes expressed at lower levels in hiPS-HEP were fructose-1,6-229 biphosphatase 1 (FBP1), glutamic-oxaloacetic transaminase 1 (GOT1), pyruvate carboxylase (PC) and 230 phosphoenolpyruvate carboxykinase 1 (PCK1), compared to hphep d0. On the other hand, Glycerol-231 3-phosphate dehydrogenase (GPD2), glycogen synthase 1 (GYS1), Oxoglutarate Dehydrogenase
232
(OGDH), and hexokinase 2 (HK2) showed higher mRNA expression levels in hiPS-HEP compared to 233 hphep d0 and/or d1. Interestingly, PC, PCK1, FBP1, GOT1, and GPD2 are directly involved in 234 gluconeogenesis, and OGDH has a strong influence on 2-oxoglutarate, which regulates the 235 gluconeogenesis in the liver [31] . Noteworthy is that PC, PCK1, and FBP1 were also significantly lower 236 expressed in hphep d1 than in hphep d0.
237
One important hepatocyte function in glucose metabolism is the ability to synthesize and store 238 glycogen (glycogenesis). Therefore, periodic acid Schiff (PAS) staining was performed on both hiPS-
239
HEP at day 12 after thaw and on hphep at day 1 after thaw. As shown in figure 3C1 -3, glycogen was 240 detected in a subset of hiPS-HEP (derived from all three hiPSC lines). Similarly, hphep also showed 241 glycogen storage in a subpopulation of the cells (Fig, 3C4 ). The presence of glycogen is in agreement 242 with the finding that several key enzymes of glycogenesis are well expressed in hiPS-HEP:
243
Hexokinase (HK), UDP-glucose pyrophosphorylase (UGP2), glycogen synthase (GYS), and Glycogen 244 branching enzyme (GBE1; Figure 3A ).
245
Another essential feature of metabolically functional hepatocytes is the physiological response 246 to insulin. Thus, the mRNA expression of 19 genes involved in insulin signaling were compared in 247 hiPS-HEP and hphep and no significant differences in expression levels of these 19 genes were found 248 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 14 November 2019 doi:10.20944/preprints201911.0162.v1
between the two cell types ( Figure 3B ), including key genes such as insulin receptor (INSR), insulin 249 receptor substrate 1 and 2 (IRS1, IRS2), and AKT serine/threonine kinases 1 and 2 (AKT1, AKT2). In 250 order to test if the hiPS-HEP respond to an insulin stimulus by phosphorylation of AKT kinase which 251 is a key regulator in the insulin signaling cascade, the hiPS-HEP were incubated for 3 hours in an 252 insulin-free medium followed by an incubation for 10 minutes with 100nM insulin. In the insulin-253 treated cells, a significant increase of phosphorylated AKT could be detected compared to untreated 254 control cells, while the total AKT content was similar in treated and untreated cells, as shown by
255
Western Blot ( Figure 3D ). Figure 4C ) and an even stronger 281 accumulation could be seen after 24 hours (data not shown).
282
The assessment of 48 genes involved in fatty acid metabolism revealed that only three genes 283 were expressed at different levels in hiPS-HEP and hphep d0 ( Figure 4B ). The exceptions were acetyl-
284
CoA carboxylase beta (ACACB) and bile acyl-CoA synthetase (SLC27A5), which were both expressed 285 at lower levels in hiPS-HEP, and protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2),
286
which was expressed at higher levels in hiPS-HEP than in hphep d0. Additionally, three genes were 287 significantly different in hiPS-HEP compared to hphep d1; HACD3 and PECR (both higher in hiPS-288 HEP); and PPARD (lower in hiPS-HEP). Noteworthy, PECR was also higher in hphep d1 compared 289 to hphep d0, and PPARD and SLC27A5 were also lower in hphep d1 compared to hphep d0. Figure 5A ). However, a few genes are expressed 309 at high levels in both cell types, e.g., AIMP1, ATRN, F11R, ITCH, MIF, PLAA, PRDX5, and RELA.
291
310
When comparing expression levels between hiPS-HEP and hphep d0/1, we found the majority 311 of the genes to be similarly expressed ( Figure 5A ) which is similar to previous results (Figure 3, 4) .
312
Only 12 out of the 72 genes differed significantly in expression levels between the two cell types:
313
CCL16, CRP, FOS, LTBR, and ORM1 were lower expressed in hiPS-HEP, whereas AXL, CYBA, F2R,
314
F2RL1, and RIPK2 were expressed at higher levels in hiPS-HEP.
315
Inflammation in the liver can, amongst others, be caused by fat accumulation. At first, fat is 316 accumulated in the hepatocytes, a condition known as NAFLD, which can progress to NASH which 317 is characterized by steatosis, inflammation, and fibrosis [16] . To model these conditions in vitro, one 318 prerequisite is that hepatocytes can take up free fatty acids and store as lipid droplets. Therefore, we 
326
Next, we investigated if inducing steatosis by treatment with OA and Thapsigargin caused an 327 inflammatory response in the hiPS-HEP. Indeed, we found that the mRNA expression of the 328 inflammatory marker tumor necrosis factor α (TNFα) was upregulated in OA/Thapsigargin-treated 329 hiPS-HEP ( Figure 5C ). The strongest upregulation of TNFα was caused by 600µM OA, followed by 
359
one needs to co-culture hepatocytes and HSC. Therefore, we adapted the culture conditions in a way 360 that allowed co-culturing primary human HSC together with hiPS-HEP. In order to activate HSC, we 361 treated the co-cultures with 20ng/ml TGFβ for 4 days which strongly increased the protein expression 362 of α-SMA ( Figure 5D2 ), a characteristic marker for activated HSC, compared to untreated cultures 363 ( Figure 5D1) . HNF4α immunostainings were comparable in controls and TGFβ-treated cultures,
364
indicating no major effect of TGFβ treatment on the hiPS-HEP cell density ( Figure 5D1 -2).
365
Since activated HSC are known to express collagens, we investigated collagen mRNA expression 366 in the co-cultures after TGFβ treatment. In accordance with the observed increase in α-SMA 367 expression upon TGFβ stimulation ( Figure 5D2 ), we also observed increased Collagen 1a1 and 5a1 368 mRNA expression in the TGFβ-treated co-cultures compared to hiPS-HEP cultures without HSC
369
( Figure 5D3,4) . Monocultures of hiPS-HEP alone showed no Collagen 1a1 expression irrespective of 370 treatment ( Figure 5D3 ), whereas Collagen 5a1 was expressed in untreated hiPS-HEP monocultures 371 and upregulated upon TGFβ treatment, however at lower levels than in the co-cultures ( Figure 5D4 ).
372
As expected, HNF4α mRNA expression was lower in co-cultures than in the hiPS-HEP monocultures 373 and was not affected by TGFβ treatment of the hiPS-HEP monocultures ( Figure 5D5 ).
374
Taken together, the co-cultures responded as expected to TGFβ treatment with activation of the 375 HSC and upregulation of α-SMA and collagen expression. However, already the untreated control 376 co-cultures displayed a weak α-SMA immunostaining ( Figure 5D1 ) which indicated that a 377 subpopulation of the HSC was already activated. This is in agreement with previous reports that HSC 378 get activated in 2D cultures due to the stiff matrix [17] . In order to avoid the HSC activation due to 379 the 2D culture setting, we generated spheroids of hiPS-HEP and HSC. To this end, we seeded hiPS-
380
HEP and HSC in ultra-low attachment plates, spheroids formed within 1-2 days and could be 381 maintained for at least 35 days ( Figure 5E1-3) . In future studies, the utility of the co-culture spheroids 382 for NAFLD and NASH studies can be explored.
384
Similarities and differences between hiPS-HEP and hphep 385
To further assess the similarities and differences between hiPS-HEP and hphep on gene 386 expression level, a global analysis of the transcriptomics data was carried out. Figure 6A Using a generalized linear model (GLM) and the criterion described in the method section, in 394 total 2,866 differentially expressed genes (DEGs) were detected as significant in at least one of the 395 sample group comparisons. Figure 6B displays the overlap of DEGs between the three group 396 comparisons. Out of these DEGs, only 76 genes are differentially expressed between all sample group 397 comparisons. 2,655 genes are differentially expressed when comparing hiPS-HEP to hphep, either at 398 day 0 or day 1 (Figure 6B, A2-A7 ). Approximately 25% of these genes are also differentially expressed 399 between hphep at day 1 and hphep at day 0 ( Figure 6B, A2, A4, A6) . To assess the biological relevance 400 of the DEGs, a pathway over-representation analysis was carried out on the different groups of DEGs 401 according to the overlapping areas (A1-A7) in figure 6B . For a complete list of significant over-
402
represented pathways, see Supplemental table 1 . Among the 76 DEGs that differ between all three 403 groups (Figure 6B, A4) there is an over-representation for pathways such as, "Cytochrome P450 -404 arranged by substrate type", "CYP2E1 reactions", "Phase I -Functionalization of compounds",
405
"Phase II -Conjugation of compounds", as well as pathways related to bile acids and bile salts. These 406 pathways are also over-represented in the comparison between hphep d1 and hphep d0 ( Figure 6B , 407 A1), as well as in the overlap between hphep d1 vs hphep d0 and hiPS-HEP vs hphep d0 ( Figure 6B , 408 A2, A4). The genes CYP2E1, CYP4A11, and CYP2C8, associated with the CYP P450 pathways, have 409 the following expression rank between the groups: hphep d0 > hphep d1 > hiPS-HEP. The same 410 expression pattern is seen for the bile acid/bile salts related genes (SLC27A5, SLCO1B1, AKR1C4).
411
The genes associated with "Phase II - 
414
The DEGs in hiPS-HEP compared to hphep d1 ( Figure 6B, A7) show an over-representation for 
434
The present study covers an in-depth characterization of hiPSC-derived hepatocytes including 435 multiple phenotypic and functional aspects of relevance for several application areas, for example 436 modeling of metabolic disease.
437
An essential requirement for the utility of stem cell-derived hepatocytes for all application areas 438 is that homogenous hepatocyte cultures can be robustly derived from large panels of stem cell lines.
439
To 
717
Briefly, the cells were carefully washed twice with pre-warmed Williams' medium E (Phenol-red free, 718 + 0.1% PEST). Then, the activity assay was started by adding 110 µl/cm2 culture area of pre-warmed
719
Williams' medium E (phenol-red free) containing 0.1% PEST, 25 mM HEPES (H7523, Sigma), 2 mM 720 L-Glutamine, and the probe substrate cocktail (see Table 2 
726
(determined using the Pierce BCA Protein Assay Kit, see above) and the assay duration (120 min). To 727 be able to normalize the results between different LCMS runs, a metabolite cocktail with known 728 concentrations of all metabolites is included in every analysis batch. 823 9. Jungermann, K. and T. Kietzmann, Zonation of parenchymal and nonparenchymal metabolism in liver.
730
